Skip to Content

Jean-Nicolas Vauthey, MD

Present Title & Affiliation

N/A

Bio Statement

 Dr. Vauthey is Professor of Surgery and Chief of the Liver Service in the Department of Surgical Oncology at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. Dr. Vauthey’s clinical research focuses on methods to measure and to improve outcome after hepatic resection for hepatobiliary malignancies. Dr. Vauthey proposed a standardized method for calculating the volume of the anticipated liver remnant prior to major liver resection. This method of measurement is used to compare patients prior to extended liver resection to determine the need for preoperative portal vein embolization. Dr. Vauthey created the International Cooperative Study Group for Hepatocellular Carcinoma. The group critically analyzed the staging system for hepatocellular carcinoma and questioned its complexity. On the basis of this work, American Joint Committee on Cancer and the International Union Against Cancer adopted a new simplified staging system for hepatocellular carcinoma.

 Dr. Vauthey has been an invited speaker at many major national and international meetings, including the postgraduate courses of the Society for Surgery of the Alimentary Tract, the American College of Surgeons, and the European Society of Surgical Oncology. Dr. Vauthey organized and moderated symposia at national and international meetings (Society of Surgical Oncology, American College of Surgeons, International Hepato-Pancreato-Biliary Association). Dr. Vauthey co-authored more than 241 publications in peer-reviewed journals and more than 36 reviews or book chapters.  

Education & Training

Degree-Granting Education

1983 Lausanne University Medical School, Lausanne, Switzerland, MD, Medical Doctor Thesis
1979 Lausanne University Medical School, Lausanne, Switzerland, MD, Swiss Federal Medical Diploma
1973 Gymnase of Vevey, Vevey, Switzerland, BA, Physics and Biology

Board Certifications

11/1990 American Board of Surgery

Selected Publications

Peer-Reviewed Original Research Articles
1. Chun YS, Laurent A, Maru D, Vauthey JN. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncology 10(3):278-286, 3/2009.
2. Abdalla EK, VautheyJN. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful or harmful? Dig Surg 25(6):421-429, 2/2009.
3. Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Vauthey JN. Is embolization of segment 4 portal veins prior to extended right hepatectomy justified? Surgery 144(5):744-751, 11/2008.
4. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C. Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years afer carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063-3072, 6/2008.
5. Ribero D, Curley SA, Imamura H, Madoff DC, Nagorney DM, Ng KK, Donadon M, Vilgrain V, Torzilli G, Roh M, Vauthey JN. Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol 15(4):986-992, 4/2008.
6. Abdalla EK, Denys A, Hasegawa K, Leung TW, Makuuchi M, Murthy R, Ribero D, Zorzi D, Vauthey JN, Torzilli G. Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol 15(4):979-985, 4/2008.
7. Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM, Wei SH, Vauthey JN. Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg 12((1)):123-128, 1/2008.

Last updated: 9/17/2009